This cohort study examines the association between antidiabetic medication and prostate-specific antigen (PSA) levels, frequency of PSA testing and biopsy, and detection of prostate cancer at biopsy among Swedish men with diabetes. Here, KLK3 is linked to prostate carcinoma.